Trial intelligence / Profile preview

Postoperative ankle motor strength after popliteal plexus block vs IPACK for total knee arthroplasty

jRCT1041230135Completed

Start
Jan 2024
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of levobupivacaine in knee osteoarthritis (OA), rheumatoid arthritis (RA) and disorders of knee (2 arms). Primary endpoint: Maximum voluntary isometric contraction (MVIC) of ankle joint motion (dorsiflexion and plantar flexion) – primary. Started Jan 2024; status: completed.

02

Drugs

levobupivacaine
03

Conditions

knee osteoarthritis (OA)rheumatoid arthritis (RA)disorders of knee

Beyond the preview

Go deeper on jRCT1041230135.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1041230135.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call